EP Patent

EP4436554A1 — Pharmaceutical compositions comprising eltrombopag

Assigned to Galenicum Health Slu · Expires 2024-10-02 · 2y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising eltrombopag or any acceptable pharmaceutical salt thereof and a non-reducing disaccharide as diluent. Manufacturing processes of such formulations are also described.

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising eltrombopag or any acceptable pharmaceutical salt thereof and a non-reducing disaccharide as diluent. Manufacturing processes of such formulations are also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP4436554A1
Jurisdiction
EP
Classification
—
Expires
2024-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Galenicum Health Slu
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.